ImmunoBiology Ltd (ImmBio) - Articles and news items

Pneumococcal vaccine PnuBioVax safe and immunogenic in Phase I study

Industry news / 30 June 2016 / Victoria White, Digital Content Producer

ImmBio has reported positive results from the First-in-Human study of its novel vaccine, PnuBioVax, against the bacterial pathogen Streptococcus pneumoniae…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+